Paracetamol and ibuprofen combination for the management of acute mild-to-moderate pain in children: expert consensus using the Nominal Group Technique (NGT).
Acute pain
Children
Fixed-dose
Ibuprofen
Paracetamol
Pediatric
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
21 Mar 2023
21 Mar 2023
Historique:
received:
02
01
2023
accepted:
14
03
2023
entrez:
22
3
2023
pubmed:
23
3
2023
medline:
24
3
2023
Statut:
epublish
Résumé
Acute pain is a common symptom in children of all ages, and is associated with a variety of conditions. Despite the availability of guidelines, pain often remains underestimated and undertreated. Paracetamol and ibuprofen are the most commonly used drugs for analgesia in Pediatrics. Multimodal pain management by using a combination of paracetamol and ibuprofen results in greater analgesia. An investigation using the Nominal Group Technique was carried out between May and August 2022. Two open (non-anonymous) questionnaires were consecutively sent to a Board of ten clinicians to understand their opinions on the use of the oral paracetamol and ibuprofen association. Answers were examined in a final meeting where conclusions were drawn. The board achieved a final consensus on a better analgesic power of paracetamol and ibuprofen in fixed-dose combination as compared to monotherapy, without compromising safety. Strong consensus was reached on the opinion that the fixed-dose combination of paracetamol and ibuprofen may be a useful option in case of inefficacy of one or other drug as monotherapy, especially in case of headaches, odontalgia, earache, and musculoskeletal pain. The use of the fixed combination may be also considered suitable for postoperative pain management. The use of the fixed-dose combination may represent advantage in terms of efficacy and safety, allowing a better control of the dose of both paracetamol and ibuprofen as monotherapy, thus minimizing the risk of incorrect dosage. However, the limited evidence available highlights the need for future well designed studies to better define the advantages of this formulation in the various therapeutic areas.
Sections du résumé
BACKGROUND
BACKGROUND
Acute pain is a common symptom in children of all ages, and is associated with a variety of conditions. Despite the availability of guidelines, pain often remains underestimated and undertreated. Paracetamol and ibuprofen are the most commonly used drugs for analgesia in Pediatrics. Multimodal pain management by using a combination of paracetamol and ibuprofen results in greater analgesia.
METHODS
METHODS
An investigation using the Nominal Group Technique was carried out between May and August 2022. Two open (non-anonymous) questionnaires were consecutively sent to a Board of ten clinicians to understand their opinions on the use of the oral paracetamol and ibuprofen association. Answers were examined in a final meeting where conclusions were drawn.
RESULTS
RESULTS
The board achieved a final consensus on a better analgesic power of paracetamol and ibuprofen in fixed-dose combination as compared to monotherapy, without compromising safety. Strong consensus was reached on the opinion that the fixed-dose combination of paracetamol and ibuprofen may be a useful option in case of inefficacy of one or other drug as monotherapy, especially in case of headaches, odontalgia, earache, and musculoskeletal pain. The use of the fixed combination may be also considered suitable for postoperative pain management.
CONCLUSIONS
CONCLUSIONS
The use of the fixed-dose combination may represent advantage in terms of efficacy and safety, allowing a better control of the dose of both paracetamol and ibuprofen as monotherapy, thus minimizing the risk of incorrect dosage. However, the limited evidence available highlights the need for future well designed studies to better define the advantages of this formulation in the various therapeutic areas.
Identifiants
pubmed: 36945023
doi: 10.1186/s13052-023-01445-4
pii: 10.1186/s13052-023-01445-4
pmc: PMC10031994
doi:
Substances chimiques
Acetaminophen
362O9ITL9D
Analgesics, Non-Narcotic
0
Drug Combinations
0
Ibuprofen
WK2XYI10QM
Types de publication
Consensus Development Conference
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
36Informations de copyright
© 2023. The Author(s).
Références
Paediatr Anaesth. 2018 Dec;28(12):1087-1095
pubmed: 30375109
Ital J Pediatr. 2020 Jul 23;46(1):101
pubmed: 32703304
Minerva Pediatr. 2019 Feb;71(1):82-99
pubmed: 30574736
Acta Paediatr. 2020 Jul;109(7):1445-1449
pubmed: 31858635
Children (Basel). 2021 Sep 30;8(10):
pubmed: 34682137
Laryngoscope. 2022 Jul;132(7):1473-1481
pubmed: 34559405
J Emerg Med. 2020 May;58(5):725-732
pubmed: 32247660
Eur J Pediatr. 2017 Jul;176(7):979-982
pubmed: 28600631
Paediatr Anaesth. 2018 Oct;28(10):841-851
pubmed: 30117229
CNS Drugs. 2021 Jan;35(1):105-120
pubmed: 33428176
Int J Clin Pharm. 2021 Dec;43(6):1705-1717
pubmed: 34633625
Ital J Pediatr. 2019 Dec 3;45(1):156
pubmed: 31796092
J Anesth. 2020 Jun;34(3):421-433
pubmed: 32236681